Clinical trials neuro-oncology

Clinical trials neuro-oncology

The UMC Utrecht Brain Center participates in international, investigator-driven and pharma-initiated, phase 0-4 clinical trials. Please check for ongoing clinical trials (in Dutch).

The UMC Utrecht is sponsor and initiator of two, soon to start, national studies (randomized clinical trials) into the optimal scheduling of radiotherapy in patients with glioblastoma. These studies are funded by grants by ZonMW and KWF to dr. Joost Verhoeff, radiation oncologist.

We participate in the Dutch Drug Rediscovery Protocol (DRUP) study program. This is a prospective, non-randomized clinical trial that aims to describe the efficacy and toxicity of commercially available, targeted anticancer drugs prescribed for treatment of patients with advanced cancer with a potentially actionable variant as revealed by a genomic or protein expression test.

Back to neuro-oncology

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet